ABBOTT LABORATORIES T.ABT

Primary Symbol: ABT

Healthcare Medical Devices

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

NYSE:ABT - Post by User

ABBOTT LABORATORIES

<< Previous

Bullboard Posts

Next >>

Post by Possibleidiot01on Aug 26, 2020 8:55am

217 Views

Post# 31454254

Pi Financial predicts higher price - Cantech Letter

Also cited in the update was Shopify, on which Papageorgiou and Kwan maintained their “Buy” rating and $1540.00 target, which at press time represented a return of 16.8 per cent, and endpoint security company Absolute Software (Absolute Software Stock Quote, Chart, News TSX:ABT), on which the analysts maintained a “Buy” rating and $20.00 target, which at press time represented a projected return of 29.4 per cent.

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity